quresNews - Page 1

From Disease X to pandemics: The urgent need for new solutions

Richard Stead, CEO of Qures Group, explores the rise of pandemics and the ongoing battle against infectious diseases.

How AI platforms can help us understand ABR and the POSTABR® era

Richard Stead, CEO of The Qures Group, discusses how different AI platforms can help us define different eras of antimicrobial resistance.

Antibiotic resistance: 100 years of history

QURES Group offers a nature-inspired approach to effectively combat antibiotic resistance. Find out more now.

Innovation News Network - Free Digital eBook Library

Innovation News Network - Global Innovation Partners

Special Reports

Partner News

Special Reports Cont'd

Partner News Cont'd